- Conditions
- Aging
- Interventions
- Progressive Resistance Training, Metformin
- Behavioral · Drug
- Lead sponsor
- Philip Kern
- Other
- Eligibility
- 65 Years and older
- Enrollment
- 109 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2015 – 2018
- U.S. locations
- 2
- States / cities
- Birmingham, Alabama • Lexington, Kentucky
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–9
of 9
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Breast Feeding, Lactation
- Interventions
- Moringa Leaf Powder, Carrier
- Dietary Supplement · Other
- Lead sponsor
- Philip Kern
- Other
- Eligibility
- 7 Days to 99 Years · Female only
- Enrollment
- 100 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2026 – 2030
- U.S. locations
- 1
- States / cities
- Brooklyn, New York
- Conditions
- Obese, Metabolic Syndrome
- Interventions
- Mirabegron, Pioglitazone, Mirabegron and Pioglitazone
- Drug
- Lead sponsor
- Philip Kern
- Other
- Eligibility
- 35 Years to 65 Years
- Enrollment
- 39 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2019
- U.S. locations
- 1
- States / cities
- Lexington, Kentucky
- Conditions
- Pre-diabetes, Obesity
- Interventions
- Mirabegron 50 MG, Tadalafil 10 MG, Placebo
- Drug
- Lead sponsor
- Philip Kern
- Other
- Eligibility
- 35 Years to 65 Years
- Enrollment
- 96 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2021 – 2027
- U.S. locations
- 1
- States / cities
- Lexington, Kentucky
- Conditions
- Metabolic Syndrome, Insulin Resistance
- Interventions
- omega-3 fatty acid, placebo
- Drug
- Lead sponsor
- Philip Kern
- Other
- Eligibility
- 35 Years to 65 Years
- Enrollment
- 33 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2007 – 2015
- U.S. locations
- 1
- States / cities
- Lexington, Kentucky
- Conditions
- Obese, Normal Body Weight, Prediabetes, Metabolic Syndrome
- Interventions
- Fat biopsy, Propranolol and fat biopsy, heavy water and fat biopsy
- Procedure · Drug · Other
- Lead sponsor
- Philip Kern
- Other
- Eligibility
- 35 Years to 60 Years · Female only
- Enrollment
- 26 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2016 – 2018
- U.S. locations
- 1
- States / cities
- Lexington, Kentucky
- Conditions
- Metabolic Syndrome, Insulin Resistance, Prediabetes
- Interventions
- Pioglitazone
- Drug
- Lead sponsor
- Philip Kern
- Other
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 70 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2005 – 2011
- U.S. locations
- 2
- States / cities
- Little Rock, Arkansas • Lexington, Kentucky
- Conditions
- PreDiabetes
- Interventions
- Placebo, Mirabegron, Mirabegron 50 MG, Mirabegron 100 mg
- Drug
- Lead sponsor
- Philip Kern
- Other
- Eligibility
- 35 Years to 65 Years
- Enrollment
- 65 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2020 – 2027
- U.S. locations
- 1
- States / cities
- Lexington, Kentucky
- Conditions
- Obese, Insulin Resistance, Metabolic Syndrome
- Interventions
- Rifaximin SSD, Placebo
- Drug · Other
- Lead sponsor
- Philip Kern
- Other
- Eligibility
- 35 Years to 65 Years
- Enrollment
- 12 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2019
- U.S. locations
- 1
- States / cities
- Lexington, Kentucky